09997 KANGJI MEDICAL
- 7.240
- -0.030-0.41%
KANGJI MEDICAL News
康基醫療：2023年度報告
Getting In Cheap On Kangji Medical Holdings Limited (HKG:9997) Is Unlikely
When close to half the companies in Hong Kong have price-to-earnings ratios (or "P/E's") below 9x, you may consider Kangji Medical Holdings Limited (HKG:9997) as a stock to avoid entirely with its 15.
KANGJI MEDICAL To Go Ex-Dividend On May 29th, 2024 With 0.45193 HKD Dividend Per Share And 1.09125 HKD Special Dividend Per Share
March 21st - $KANGJI MEDICAL(09997.HK)$ is trading ex-dividend on May 29th, 2024. Shareholders of record on May 30th, 2024 will receive 0.45193 HKD dividend per share and 1.09125 HKD special divid
Kangji Medical Holdings' Profit Rises 5% in 2023
Kangji Medical Holdings' (HKG:9997) attributable profit increased 5.3% to 504 million yuan, or 0.4299 yuan per share, in 2023, from 478.7 million yuan, or 0.3963 yuan per share, in 2022, according to
Changes in Hong Kong stocks | Kangji Healthcare (09997) fell more than 5% in the morning, net profit for the whole year increased by 5.3%, and the company cancelled the merger of Weijing Healthcare
Kangji Healthcare (09997) opened high and went low in early trading, falling more than 5% in the morning. As of press release, it was down 4.99% to HK$7.05, with a turnover of HK$23.9852 million.
Kangji Healthcare Announces Cancellation of Merger with Weijing Healthcare
Kangji Healthcare (09997) issued an announcement. On March 20, 2023, Weijing Healthcare shareholders approved a number of revisions to Weijing Healthcare's organizational rules and changes in the composition of the board of directors. According to the revised Articles of Association of Weizheng Healthcare, the number of directors that Kangji Hong Kong is authorized to appoint has been reduced from 4 to 3 of the 7 directors of Weijing Healthcare's board of directors. As a result, Kangji Hong Kong will no longer be able to appoint most of the board members of Weijing Healthcare and will lose control of Weijing Healthcare. After the change in the composition of the board of directors takes effect, Weijing Medical will no longer be a subsidiary of the company, and Weijing Medical's financial performance will no longer be incorporated into the company
Kangji Healthcare (09997) announced its 2023 annual results. Profit attributable to shareholders was 504 million yuan, an increase of 5.3% over the previous year
Kangji Healthcare (09997) announced its annual results for the year ended December 31, 2023, with revenue of 926 million yuan (...
Kangji Healthcare (09997.HK) cancels merger with Weijing Healthcare
Gelonghui, March 20, 丨 Kangji Medical (09997.HK) announced that on March 20, 2024, Weijing Healthcare shareholders have approved several amendments to Weijing Healthcare's organizational rules and changes in the composition of the board of directors. According to the revised Articles of Association of Weizheng Healthcare, the number of directors that Kangji Hong Kong is authorized to appoint has been reduced from 4 to 3 of the 7 directors of Weijing Healthcare's board of directors. As a result, Kangji Hong Kong will no longer be able to appoint most of the board members of Weijing Healthcare and will lose control of Weijing Healthcare. After the change in the composition of the board of directors takes effect, Weijing Medical will no longer be a subsidiary of the company, and Weijing Medical's finances
Kangji Healthcare (09997) will pay a final dividend of $0.41 per share on July 18
Kangji Healthcare (09997) announced that the company will pay a final dividend per share on July 18, 2024...
KANGJI MEDICAL: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023
Is Kangji Medical Holdings Limited (HKG:9997) Worth HK$6.2 Based On Its Intrinsic Value?
Key Insights Using the 2 Stage Free Cash Flow to Equity, Kangji Medical Holdings fair value estimate is HK$4.70 Current share price of HK$6.22 suggests Kangji Medical Holdings is potentially 32% ove
Kangji Healthcare (09997.HK) plans to hold a board meeting on March 20 to approve annual results
GLONGHUI March 4 | Kangji Healthcare (09997.HK) announced that the company will hold a board meeting on March 20, 2024 (Wednesday) to consider and approve the results of the company and its subsidiaries for the year ended 31 December 2023 and their announcements and proposals for payment of a final dividend (if any).
KANGJI MEDICAL: NOTICE OF BOARD MEETING
Kangji Healthcare (09997) cancelled 1.971,000 repurchased shares on January 31
Kangji Healthcare (09997) issued an announcement to cancel a total of 1.971,000 shares and have been repurchased on January 31, 2024...
Kangji Medical Holdings Limited's (HKG:9997) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
It is hard to get excited after looking at Kangji Medical Holdings' (HKG:9997) recent performance, when its stock has declined 15% over the past month. However, stock prices are usually driven by a
Kangji Medical spent approximately HK$824,400 to buy back 125,500 shares on January 18
Kangji Healthcare (09997) announced that on January 18, 2024, it spent approximately HK$824,400 to repurchase 125,500 shares at a repurchase price of HK$6.52-6.61 per share.
Kangji Healthcare (09997) spent approximately HK$824,400 to buy back 125,500 shares on January 18
According to the Zhitong Finance App, Kangji Healthcare (09997) announced that on January 18, 2024, it spent approximately HK$824,400 to repurchase 125,500 shares, with a repurchase price of HK$6.52-6.61 per share.
Kangji Medical spent approximately HK$961,200 to buy back 150,000 shares on January 17
Kangji Healthcare (09997) announced that on January 17, 2024, it spent approximately HK$961,200 to repurchase 150,000 shares at a repurchase price of HK$6.37-6.43 per share.
Kangji Healthcare (09997) spent about HK$961,200 to buy back 150,000 shares on January 17
According to the Zhitong Finance App, Kangji Healthcare (09997) announced that on January 17, 2024, it spent approximately HK$961,200 to repurchase 150,000 shares at a repurchase price of HK$6.37-6.43 per share.
Kangji Medical spent about HK$669,400 to buy back 100,000 shares on January 16
Kangji Healthcare (0997) announced that it spent approximately HK$669,400 to repurchase 100,000 shares on January 16, 2024.
Analysis
Price Target
No Data
